Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 48000 questions Show Answers
To ask the Scottish Government what baseline data was used to determine the scale of need for play park renewal prior to distributing the £60 million of funding.
To ask the Scottish Government what its response is to the Additional Support for Learning: Findings Report, published by the Scottish Assembly of Parents and Carers on 27 May 2025.
To ask the Scottish Government what steps it is taking to ensure that everyone diagnosed with ovarian cancer is able to access ovarian cancer surgery regardless of where they live.
To ask the Scottish Government what assessment it has made of reports that over 70% of brain cancer patients are diagnosed in an emergency setting, which is the highest of any cancer type.
To ask the Scottish Government what medical pathways are available to those experiencing symptoms associated with topical steroid withdrawal.
To ask the Scottish Government what guidance it provides to local authorities regarding minimum levels of additional support needs staff, such as additional needs assistants, in secondary schools.
To ask the Scottish Government what action it is taking to support people who are reporting topical steroid withdrawal.
To ask the Scottish Government what steps are being taken to reduce ovarian cancer surgery waiting lists in the south of Scotland.
To ask the Scottish Government how it evaluates whether local authorities, including Scottish Borders Council, are fulfilling their duties under the Education (Additional Support for Learning) (Scotland) Act 2004.
To ask the Scottish Government whether it will provide additional funding or support to NHS boards to help administer early access programmes for (a) givinostat and (b) other treatments for rare diseases.